Breadcrumb
- Home
- Publications
- Proceedings
- 2005 Annual Meeting
- Food, Pharmaceutical & Bioengineering Division
- Modeling, Analysis, and Control in Biomedicine
- (173c) A Model of the Darwinian Evolution of Cancer Progression
The highest fidelity cancer progression models are written in terms of ordinary differential equations (ODEs) that track the progression of cancer as a series of mutations characterized by a set of kinetic parameters and rate expressions describing mutation, birth, death, and metastatic rates (e.g., Spencer et al, 2004). The kinetic parameters are mostly inferred from various sets of experimental data available in the literature. While such models have been able to model much of the qualitative observations during cancer progression, a drawback of ODE-based models is that they do not track differences between cells within each distinct cell population such as the cell age or number of cell divisions for each cell. This is a significant limitation, as more realistic expressions for some of the cancer cell kinetic rates are strongly dependent on the cell age.
Population balance models, on the other hand, can and have been used extensively to model heterogeneity in noncancerous cell populations (e.g., see Henson, 2003, and citations therein). In this work, we propose a population balance model to adequately account for the age and replicative potential of cells in order to more accurately model the six-step progression of cancer. The model is extended to include spatial variations, using a spatially-varying population balance equation (Hulbert and Katz, 1964). The model equations are simulated using a high resolution finite volume algorithm (Gunawan et al, 2004, LeVeque, 2002), which is followed by sensitivity analysis (Caracotsios and Stewart, 1985) and uncertainty analysis for nonlinear distributed parameter systems (Hukkanen and Braatz, 2005) to assess which kinetic parameters have the strongest effect on the tumor cell populations and to quantify the effects of simultaneous uncertainties. These results are compared to experimental data on the biological variability of tumor progression from person to person, and used to assess the extent for which state-of-the-art cancer progression models are accurate enough for use in optimal chemotherapy studies.
References:
M. Caracotsios and W. E. Stewart. Sensitivity analysis of initial-value problems with mixed odes and algebraic equations. Comp. & Chem. Eng., 9, 359-365, 1985.
R. Gunawan, I. Fusman, and R. D. Braatz. High resolution finite volume methods for simulating multidimensional population balance equations with nucleation and size-dependent growth. AIChE J., 50, 2738-2749, 2004.
Douglas Hanahan and Robert A. Weinberg. The hallmarks of cancer. Cell, 100, 57-70, 2000.
E. J. Hukkanen and R. D. Braatz. Worst-case and distributional robustness analysis of the full molecular weight distribution during free radical bulk polymerization. Proceedings of the American Control Conference, Portland, OR, June 8-10, 2005, and references cited therein.
H. M. Hulbert and S. Katz. Some problems in particle technology. Chem. Eng. Sci., 19, 555, 1964.
Michael A. Henson. Dynamic modeling of microbial cell populations. Current Opinion in Biotechnology, 14, 460-467, 2003.
R. J. LeVeque. Finite Volume Methods for Hyperbolic Problems. Cambridge University Press, New York, 2002.
Sabrina L. Spencer, Matthew J. Berryman, Jose A. Garcia, and Derek Abbott. An ordinary differential equation model for the multistep transformation to cancer. J. of Theoretical Biology, 231, 515-524, 2004.